Get the Stockscreener App
24.81
3.03%
0.73
After Hours:
24.81
Sol Gel Technologies Ltd stock is traded at $24.81, with a volume of 13,240.
It is up +3.03% in the last 24 hours and up +62.69% over the past month.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
See More
Previous Close:
$24.08
Open:
$24.08
24h Volume:
13,240
Relative Volume:
0.61
Market Cap:
$69.11M
Revenue:
$23.93M
Net Income/Loss:
$-3.41M
P/E Ratio:
-21.76
EPS:
-1.14
Net Cash Flow:
$-33.87M
1W Performance:
-11.27%
1M Performance:
+62.69%
6M Performance:
+310.83%
1Y Performance:
+293.81%
1-Day Range:
$23.22
$24.85
1-Week Range:
$23.13
$28.97
52-Week Range:
$4.006
$30.00
Sol Gel Technologies Ltd Stock (SLGL) Company Profile
Name
Sol Gel Technologies Ltd
Sector
Industry
Phone
-
Address
-
Compare SLGL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLGL
Sol Gel Technologies Ltd
|
24.81 | 66.72M | 23.93M | -3.41M | -33.87M | -1.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-21-22 | Resumed | Jefferies | Hold |
| Dec-31-19 | Reiterated | H.C. Wainwright | Buy |
| Dec-31-19 | Reiterated | JMP Securities | Mkt Outperform |
Sol Gel Technologies Ltd Stock (SLGL) Latest News
Identifying reversal signals in Sol Gel Technologies Ltd.Earnings Trend Report & High Conviction Investment Ideas - Newser
How to interpret RSI for Sol Gel Technologies Ltd. stockQuarterly Market Summary & Verified Momentum Stock Alerts - Newser
How to monitor Sol Gel Technologies Ltd. with trend dashboardsInflation Watch & Community Shared Stock Ideas - Newser
Will Sol Gel Technologies Ltd. stock go up soonQuarterly Investment Review & Real-Time Market Sentiment Alerts - Newser
How to integrate Sol Gel Technologies Ltd. into portfolio analysis toolsWeekly Profit Report & Low Drawdown Investment Ideas - Newser
How to track smart money flows in Sol Gel Technologies Ltd.2025 Valuation Update & Weekly Breakout Watchlists - Newser
Order flow analysis tools used on Sol Gel Technologies Ltd.July 2025 Short Interest & Accurate Buy Signal Alerts - Newser
Is Sol Gel Technologies Ltd. stock bottoming outJuly 2025 Retail & Safe Swing Trade Setups - Newser
Key resistance and support levels for Sol Gel Technologies Ltd.Weekly Trading Summary & Risk Managed Investment Strategies - Newser
Applying Elliott Wave Theory to Sol Gel Technologies Ltd.Dollar Strength & Free Reliable Trade Execution Plans - Newser
Using R and stats models for Sol Gel Technologies Ltd. forecasting2025 Bull vs Bear & Safe Capital Growth Tips - Newser
What does recent volatility data suggest for Sol Gel Technologies Ltd.2025 Winners & Losers & Weekly Setup with High ROI Potential - Newser
Can swing trading help recover from Sol Gel Technologies Ltd. losses2025 Earnings Impact & Consistent Return Investment Signals - Newser
Short Interest in Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Drops By 36.6% - MarketBeat
News impact scoring models applied to Sol Gel Technologies Ltd.Market Sentiment Summary & AI Optimized Trading Strategy Guides - Newser
Published on: 2025-09-11 17:27:04 - Newser
Sol-Gel Technologies Secures Health Canada Approval for EPSOLAY - MSN
Will Sol Gel Technologies Ltd. continue its uptrendAnalyst Downgrade & Low Risk Profit Maximizing Plans - Newser
Market reaction to Sol Gel Technologies Ltd.’s recent newsTrade Risk Report & Community Consensus Stock Picks - Newser
Volume spikes in Sol Gel Technologies Ltd. stock – what they meanChart Signals & AI Enhanced Market Trend Forecasts - Newser
What to do if you’re stuck in Sol Gel Technologies Ltd.Market Weekly Review & Verified Chart Pattern Trade Signals - Newser
Basal Cell Neoplasms Clinical Trial Pipeline Accelerates as 22+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - GlobeNewswire Inc.
Will Sol Gel Technologies Ltd. stock recover after recent dropEarnings Beat & Reliable Trade Execution Plans - Newser
Using economic indicators to assess Sol Gel Technologies Ltd. potentialShare Buyback & AI Powered Market Entry Strategies - Newser
Is Sol Gel Technologies Ltd. trending in predictive chart models2025 Retail Activity & Free Accurate Trade Setup Notifications - Newser
How to escape a deep drawdown in Sol Gel Technologies Ltd.July 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - Newser
Sentiment analysis tools applied to Sol Gel Technologies Ltd.Portfolio Risk Report & Weekly High Conviction Trade Ideas - Newser
Chart overlay techniques for tracking Sol Gel Technologies Ltd.Market Growth Report & High Conviction Investment Ideas - Newser
Best data tools to analyze Sol Gel Technologies Ltd. stock2025 Retail Activity & Reliable Volume Spike Trade Alerts - Newser
Using Bollinger Bands to evaluate Sol Gel Technologies Ltd.Earnings Trend Report & Weekly High Return Forecasts - Newser
Does Sol Gel Technologies Ltd. have strong EBITDA margins2025 Pullback Review & Weekly Top Performers Watchlists - Lancaster City Council
Can Sol Gel Technologies Ltd. outperform in the next rally2025 Bull vs Bear & Free Community Consensus Stock Picks - Lancaster City Council
Sol Gel Technologies Ltd Stock (SLGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):